APAC Cardiac Arrhythmia Monitoring Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 1.80 Billion |
| Market Size (2029) | USD 2.67 Billion |
| CAGR (2024 - 2029) | 8.22 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
APAC Cardiac Arrhythmia Monitoring Devices Market Analysis
The Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market size is estimated at USD 1.8 billion in 2024, and is expected to reach USD 2.67 billion by 2029, growing at a CAGR of 8.22% during the forecast period (2024-2029).
In most of the cardiac disorders, continuous cardiac monitoring is required. Although cardiac arrhythmia cannot be cured completely, the best possible way to continuously monitor the patients suffering from cardiac arrhythmia is through remote patient monitoring, by using the cardiac arrhythmia monitoring devices, which is referred to as telecardiology.
Japan has the world's fastest ageing population. According to the World Ageing 2019 report, estimates the number of the population who are above 65 years of age in Japan was 35.524 million (28%) in 2019 which is projected to reach 37.278 million (30.9%) in 2030. As the number of geriatric population is expected to increase in the coming years who are more prone to chronic diseases such as cardiovascular diseases which ultimately rises the growth of the market as this group population need monitoring of the heart which ultimately increases the use of monitoring devices in near future.
The rising incidence of heart diseases in Asia-Pacific is also influencing the healthcare service providers to implement advanced telehealth services. Hence, the increasing usage of telecardiology is expected to drive the market studied in the future.
APAC Cardiac Arrhythmia Monitoring Devices Market Trends
This section covers the major market trends shaping the APAC Cardiac Arrhythmia Monitoring Devices Market according to our research experts:
Holter Monitoring Devices Segment is Expected to Dominate the Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market
Holter monitoring devices are found dominating the market as these devices can be used for longer durations for diagnosing sporadic symptoms in suffering patients. They also offer faster and convenient monitoring to increase patient compliance and is also likely to enhance treatment outcome. Furthermore, there are several advancements taking place in the cardiac arrhythmia monitoring devices market and these advances are rapidly increasing, which in turn, is driving the cardiac arrhythmia monitoring devices market.
As per United Nations Population Fund (UNFPA) 2017 report, estimates that in India, by 2050 the number of heart disease cases in senior citizens is projected to be about 19.1 million which is expected to increase the use of cardiac monitoring devices which shows a positive impact on the market in coming years.
Hence, as the number of heart diseases is expected to increase in the near future, the prevalence of cardiac arrhythmia is also expected to increase. This will increase the demand for Holter monitoring devices, which will positively impact market growth.
APAC Cardiac Arrhythmia Monitoring Devices Industry Overview
The Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market is consolidated competitive with few major players. Market players with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness which has also helped the market grow.
APAC Cardiac Arrhythmia Monitoring Devices Market Leaders
-
Abbott Laboratories Inc
-
Biotronik
-
Medtronic PLC
-
GE Healthcare
-
Koninklijke Philips NV
*Disclaimer: Major Players sorted in no particular order
APAC Cardiac Arrhythmia Monitoring Devices Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Assumptions
-
1.2 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Use of Telecardiology
-
4.2.2 Development of Smart Cardiac Monitors
-
4.2.3 Ease of Use and Portability of Cardiac Arrhythmia Monitoring Devices
-
-
4.3 Market Restraints
-
4.3.1 High Cost of Remote Cardiac Arrhythmia Monitoring
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Device
-
5.1.1 Event Monitoring Devices
-
5.1.2 Continuous Rhythm Monitoring Devices
-
5.1.3 Holter Monitoring Devices
-
5.1.4 Other Devices
-
-
5.2 By Service Provider
-
5.2.1 Mobile Cardiac Telemetry Monitoring Service Providers
-
5.2.2 Independent Diagnostic Testing Facilities/Clinics
-
-
5.3 Geography
-
5.3.1 Asia-Pacific
-
5.3.1.1 China
-
5.3.1.2 Japan
-
5.3.1.3 India
-
5.3.1.4 Australia
-
5.3.1.5 South Korea
-
5.3.1.6 Rest of Asia-Pacific
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Abbott Laboratories
-
6.1.2 Biotronik
-
6.1.3 GE Healthcare
-
6.1.4 Medtronic PLC
-
6.1.5 Koninklijke Philips NV
-
6.1.6 AliveCor Inc
-
6.1.7 iRhythm Technologies Inc
-
6.1.8 Medi-Lynx
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
APAC Cardiac Arrhythmia Monitoring Devices Industry Segmentation
As per the scope of the report, Cardiac arrhythmia monitoring devices are used for monitoring the patients at risk or with heart arrhythmia. These devices detect and alarm the heartbeats that are irregular being either too slow or too fast. The Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market is segmented by devices, service provider, and geography.
| By Device | |
| Event Monitoring Devices | |
| Continuous Rhythm Monitoring Devices | |
| Holter Monitoring Devices | |
| Other Devices |
| By Service Provider | |
| Mobile Cardiac Telemetry Monitoring Service Providers | |
| Independent Diagnostic Testing Facilities/Clinics |
| Geography | ||||||||
|
APAC Cardiac Arrhythmia Monitoring Devices Market Research FAQs
How big is the Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market?
The Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market size is expected to reach USD 1.80 billion in 2024 and grow at a CAGR of 8.22% to reach USD 2.67 billion by 2029.
What is the current Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market size?
In 2024, the Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market size is expected to reach USD 1.80 billion.
Who are the key players in Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market?
Abbott Laboratories Inc, Biotronik, Medtronic PLC, GE Healthcare and Koninklijke Philips NV are the major companies operating in the Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market.
What years does this Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market cover, and what was the market size in 2023?
In 2023, the Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market size was estimated at USD 1.66 billion. The report covers the Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Asia-Pacific Cardiac Arrhythmia Monitoring Devices Industry Report
Statistics for the 2024 Asia-Pacific Cardiac Arrhythmia Monitoring Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Cardiac Arrhythmia Monitoring Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
